Companies: 10,795·Total market cap: $144.5T
Bionano Genomics, Inc.

Bionano Genomics, Inc.

BNGONASDAQHealthcare● Active
$1.17
+$0.00(+0.00%)
Market Cap$3841591
P/E Ratio
52W High$5.5
52W Low$1.06
Overview

Bionano Genomics, Inc. (BNGO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BNGO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-5.80bngo eps ttm · bngo earnings per shareEarnings history
PE Ratio (TTM)bngo pe ratio ttm · bngo price to earningsPE Ratio deep dive
Revenue (TTM)$28.7Mbngo revenue ttm · bngo annual revenueFull revenue history
Dividend YieldNo Dividenddoes bngo pay dividends · bngo dividend yieldDividend history
Shares Outstanding5.4Mbngo shares outstanding · bngo floatShares outstanding history
Next EarningsAug 13, 2026Est.bngo earnings date · bngo next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$28.5M▼ 7.37% YoY
202320242025
bionano genomics, inc. revenue · bngo revenue 2025
FY 2025Net Income-$26.4M▲ +76.44% YoY
202320242025
bionano genomics, inc. net income · bngo profit 2025
FY 2025EPS$-4.85▲ +94.50% YoY
202320242025
bngo eps · bionano genomics, inc. earnings per share 2025
TTM:Revenue: $28.7MNet Income: -$31.6MEPS: $-5.80View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis bngo a buy · bngo analyst rating
Strong Buy
0
Buy
4
Hold
3
Sell
0
Strong Sell
0
12-Month Price Target
$1.00Low
$1.17Current
$46.50Avg Target3874.36% upside
$175.00High
bngo price target · bngo 12 month forecast

Total: 7 · Buy rate: 57.1%

The BNGO analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $46.50, representing +3874.36% upside from the current price of $1.17.

Stock Performance

Full History
1D+0.43%
1W-6.75%
1M-8.91%
3M+4.91%
YTD-23.20%
1Y-67.98%
5Y-99.98%

About Bionano Genomics, Inc.

CEORobert Erik Holmlin
IPO DateAug 21, 2018
Employees98
CountryUS

Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analy…

what is bionano genomics, inc. · bngo stock overview · bionano genomics, inc. company profile · who is bionano genomics, inc. ceo · bngo NASDAQ · bionano genomics, inc. headquarters · bionano genomics, inc. business segments

About Stock Overview & Key Data

Bionano Genomics, Inc. (BNGO) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Aug 21, 2018. As of the latest trading session, BNGO stock price is $1.17, with a market capitalization of $3.8M. The stock has returned -67.98% over the past 12 months and -23.20% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Bionano Genomics, Inc. stock is Buy, with an average 12-month price target of $46.50. In fiscal year 2025, Bionano Genomics, Inc. reported revenue of $28.5M and net income of -$26.4M. For detailed data — including Bionano Genomics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Bionano Genomics, Inc. (BNGO) stock price is $1.17. The stock is traded on NASDAQ under the ticker symbol BNGO. The 52-week range is $1.06 – $5.50.

BNGO stock priceBNGO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice